Aravive, inc. (ARAV)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue
Grant revenue

4,753

1,371

40,000

-

-

-

-

-

Operating expenses
Research and development

12,836

11,075

-

-

-

-

-

-

Research and development

-

-

94,612

71,984

60,025

32,608

14,855

10,963

Write-off of acquired in-process research and development

-

38,313

-

-

-

-

-

-

General and administrative

13,691

27,395

29,870

24,336

22,483

13,505

4,428

1,936

Total operating expenses

26,527

76,783

124,482

96,320

82,508

46,113

19,283

12,899

Loss from operations

-21,774

-75,412

-84,482

-96,320

-82,508

-46,113

-19,283

-12,899

Interest income

1,022

989

847

514

218

132

1

-

Interest expense

-

2,429

528

-

-

-

128

393

Other (expense) income, net

2,534

519

-1,063

236

113

-11,532

913

75

Net loss before provision for income taxes

-

-

-85,226

-95,570

-82,177

-57,513

-

-

Benefit from income taxes

-

-

-247

247

-

-

-

-

Net loss

-18,218

-76,333

-84,979

-95,817

-82,177

-57,513

-18,497

-13,217

Deemed dividend related to beneficial conversion feature of convertible preferred stock

-

-

-

-

-

25,559

-

-

Accretion of Series A preferred stock to redemption value, net of extinguishment

-

-

-

-

-

-

-

0

Net loss attributable to common stockholders

-

-

-

-

-

-83,072

-18,497

-13,217

Net loss per share - basic and diluted

-1.57

-10.64

-14.47

-3.11

-2.84

-4.39

-41.10

-114.71

Weighted-average common shares used to compute basic and diluted net loss per share

11,589

7,171

5,871

30,784

28,964

18,922

450

115

Contract Revenue [Member]
Total revenue

-

-

40,000

-

-

-

-

-